CN1936009A - Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation - Google Patents

Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation Download PDF

Info

Publication number
CN1936009A
CN1936009A CN 200510017148 CN200510017148A CN1936009A CN 1936009 A CN1936009 A CN 1936009A CN 200510017148 CN200510017148 CN 200510017148 CN 200510017148 A CN200510017148 A CN 200510017148A CN 1936009 A CN1936009 A CN 1936009A
Authority
CN
China
Prior art keywords
plasmid
ppic9k
influenza virus
expression
avian influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510017148
Other languages
Chinese (zh)
Inventor
金宁一
徐一鸣
鲁会军
李昌
韩松
金扩世
Original Assignee
金宁一
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 金宁一 filed Critical 金宁一
Priority to CN 200510017148 priority Critical patent/CN1936009A/en
Publication of CN1936009A publication Critical patent/CN1936009A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention relates to an expression making method for Avian Influenza virus matrix protein. It supplies a confluence antigen protein compounded by two AIV antigen proteins, and could effectively detect A type Avian Influenza virus matrix protein and make the expression. It includes the following steps: constructing pPIC9K-M-Np, expressing and making M-Np protein Pichia pastoris eukaryon expression. It has the feature of high expression quantity, strong specificity, easy to purify and full space conformation.

Description

The expression preparation of avian influenza virus stromatin and nucleoprotein fusion antigen protein
Technical field:
The invention belongs to biological technical field, particularly relate to a kind of AIV fusion antigen protein and preparation.
Background technology:
(Avian Influenza AI) is a kind of poultry that caused by A type influenza virus and infection and/or the disease syndrome of wild fowl in bird flu.AIV have the height variability, based on hemagglutinin (Hemagglutinin, HA) and neuraminidase (Neuraminidase, NA) the antigenicity difference of two kinds of surface antigens can be divided into different hypotypes, has found 15 of HA hypotypes, 9 of NA hypotypes at present.According to influenza virus nucleoprotein (Nucleoprotein, NP) and stromatin (Matrix proteins, M) antigenic difference, influenza virus is divided into three serotypes, be A, B, C type (or claiming first, second, third type), can test by AGP between various, complement fixation test (CFT) etc. detected and distinguished.All AIV are A type influenza virus.
From Perroncito in 1878 reported first since bird flu, nineteen fifty-nine take place high pathogenic avian influenza take place in Italy, the whole world has at least breaks out on a large scale with popular for 23 times, all causes heavy economic losses at every turn.All there is breaking out with popular of this disease in world many countries and area at present.This disease is defined as the category-A transmissible disease by OIE (OIE).China also classifies it as a class animal epidemic.In Hong Kong bird flu incidents in 1997, obstacle direct infection people and cause people's death between H5N1 AIV breaks through kind first, broken H1, H2 are only arranged under the natural condition, routine that H3 subtype influenza virus can infected person, given AIV brand-new public health meaning thus.At the beginning of the year ends to 2,004 2003, successively broken out bird flu in countries and regions such as Korea S, Japan, Thailand, Vietnam, China's Mainland, TaiWan, Chinas, strain is the H5N1 hypotype.The infection of H5N1 has taken place again in China Qinghai in 2005, causes the extensive concern of the whole world to AI once more.
Bird flu is the viral deadly infectious disease of serious threat aviculture development.China is that the first in the world is supported fowl big country, support the fowl total amount and reach 10,000,000,000 plumages, in recent years, the generation of bird flu and popular, enormous economic loss and serious social influence have been caused in China, especially occurred avian influenza virus (AIV) direct infection people's incident in 1997 and 1999, at the beginning of the year ends to 2,004 2003, successively broken out bird flu in Southeast Asian countries and regions.The Asia had 53 people to infect avian influenza virus in 2004,41 people's death, and bird flu causes global extensive concern and even fear.The public health meaning of bird flu more causes common people's shock and concern, and its anti-system has been directly connected to the sustainable and stable development of China's aviculture and the people's health health.Thereby early stage quick diagnosis and immune antibody monitoring be the key of the anti-system of bird flu, and be significant.
At present, domestic and international research to AIV early diagnosis technology and detection technique has all obtained progress in various degree.Bird flu H5, H7, H9 hypotype multiplex real-time reverse transcriptase PCR detection kit are succeeded in developing in Shenzhen; The research and development of Taiwan Chung Hsing University detect ferment immunosorption reaction (ELISA) quick test cover group method of H5 and H7 antibody, can be applicable to the screening of an a large amount of serum corpse or other object for laboratory examination and chemical testing; Medical College of Shantou University, medical college of Hong Kong University associating influenza research centre and Xiamen University's cooperation research and development go out the world's first avian influenza virus H 5 N 1 rapid diagnosis kit test kit; Korea S develops a kind of simple diagnosis box that can make a definite diagnosis bird flu rapidly.Simultaneously, the development of avian influenza vaccine is also among extensively carrying out.The early diagnosis of this explanation AIV, the research that detects and prevent and treat method have caused worldwide concern.
To the diagnosis of bird flu, mainly contain methods such as checking chicken serum antibody, avian influenza virus isolation identification, detection of nucleic acids at present.And directly detect avian influenza virus antigen method relevant report seldom.In view of the present domestic AIV deactivation vaccine that begun to be extensive use of, detect serum antibody and diagnose this disease impossible; Virus is separated needs responsive animal of inoculation or culturing cell, has shortcomings such as length consuming time, complex operation; Immunofluorescence needs equipment such as fluorescent microscope, and there is subjectivity in result's judgement; The RT-PCR method requires to extract organizes RNA, and technical requirements is higher, is unsuitable for basic unit's laboratory operation.In addition, aforesaid method all is not easy to carry out the detection of batch samples, is difficult to satisfy the needs of current bird flu epidemic situation development.Enzyme linked immunosorbent assay (ELISA) has sensitivity, the incomparable advantage of other method such as accurate, quick, simple, and the bottleneck that this method is set up be whether to have a large amount of biologically actives, specific antigen protein examines and determine.Stromatin (M) is the maximum a kind of albumen of content in the viral protein of influenza virus, can guarantee the integrity of virus particle, regulates the activity of polysaccharase, is also playing an important role aspect the assembling of progeny virus particle.
Technology contents:
The invention provides a kind of fusion antigen protein of forming by two kinds of AIV antigen proteins, can effectively detect the expression preparation of the avian influenza virus stromatin of antibody and the nucleoprotein fusion antigen protein of very high A type avian influenza virus stromatin of pathogenicity rate and nucleoprotein.
The present invention at first makes up plasmid pPIC9K-M-Np: the pMD18-T-M plasmid is also reclaimed by EcoR I, EcoRV double digestion; The pMD18-T-Np plasmid is by EcoR I, EcoRV double digestion and recovery; Interstitial granules pMD18-T-M-Np during above recovery product promptly obtained after the T4 ligase enzyme connects; PMD18-T-M-Np is through EcoR I, Not I double digestion and recovery; The pPIC9K plasmid is by EcoR I, Not I double digestion and recovery; Above recovery product after connecting, the T4 ligase enzyme is promptly obtained purpose plasmid pPIC9K-M-Np;
M-Np albumen pichia spp eukaryotic expression and preparation then: with Bpu1102I linearizing pPIC9K-M-Np recombinant plasmid; After the linearizing its electricity is converted in the GS115 competence, in the MD flat board, cultivate, then the single bacterium colony of picking is recovered in the YPD substratum, put forward the recombinant gene group and carry out the PCR evaluation, the positive strain that filters out shakes bacterium in the BMGY substratum, go in the BMMY substratum after centrifugal to begin methanol induction, gets supernatant after product is centrifugal, add saturated ammonium sulphate albumen, centrifugal collection promptly gets the M-Np antigen protein.
The present invention is by avian influenza virus stromatin and nucleoprotein fusion antigen protein that aforesaid method obtained, and its gene order is SEQ ID NO:1.
Nucleoprotein (NP) is the major antigen of cytotoxic lymphocyte identification.Therefore, the present invention has carried out the research of the M-Np fusion antigen protein that utilizes pichia spp eukaryotic expression system expression preparation.Its expression amount height, high specificity, be easy to purifying, have the evaluation requirement that complete characteristics such as space conformation meet the ELISA quick detection kit fully.
1, invents the antigen protein that obtains, can detect AIV antibody in the body on the one hand; Can assist the development of AIV testing tool on the other hand and lay a good foundation for the development of AIV novel gene engineered vaccine.
2, related antigen protein in the invention, at A type AIV stromatin and nucleoprotein, popularity is strong, has very important practice significance.
3, related antigen protein in the invention utilizes the pichia spp eukaryotic expression system, and except that having good biological activity, but also great expression and purifying are easy to industrialization.
4, therefore the domestic so far amalgamation and expression that does not also utilize yeast expression system to carry out the AIV viral protein, originally delivers high novelty.
Description of drawings:
Fig. 1 is pPIC9K-M-Np plasmid construction figure of the present invention;
Fig. 2 is M-Np antigen protein eukaryotic expression of the present invention and preparation mode figure.
Embodiment:
The present invention at first makes up plasmid pPIC9K-M-Np: the pMD18-T-M plasmid is also reclaimed by EcoR I, EcoRV double digestion; The pMD18-T-Np plasmid is by EcoR I, EcoRV double digestion and recovery; Interstitial granules pMD18-T-M-Np during above recovery product promptly obtained after the T4 ligase enzyme connects; PMD18-T-M-Np is through EcoR I, Not I double digestion and recovery; The pPIC9K plasmid is by EcoR I, Not I double digestion and recovery; Above recovery product after connecting, the T4 ligase enzyme is promptly obtained purpose plasmid pPIC9K-M-Np;
M-Np albumen pichia spp eukaryotic expression and preparation then: with Bpu1102I linearizing pPIC9K-M-Np recombinant plasmid.After the linearizing its electricity is converted in the GS115 competence, cultivated 2~3 days in the MD flat board under 28 ℃ of conditions, then the single bacterium colony of picking is recovered in the YPD substratum, put forward the recombinant gene group and carry out the PCR evaluation, the positive strain that filters out shakes bacterium 16~18h under 28 ℃ of conditions in the BMGY substratum, go to after centrifugal in the BMMY substratum and begin methanol induction, get supernatant after product is centrifugal, add an amount of saturated ammonium sulphate albumen, make the ammonium sulfate final concentration reach 70%, centrifugal collection promptly gets the M-Np antigen protein.
The present invention is by avian influenza virus stromatin and nucleoprotein fusion antigen protein that aforesaid method obtained, and its gene order is SEQ ID NO:1.
Narrate implementation method of the present invention below:
1, method
1.1 the genetic manipulation of molecular biology routine
The extraction of the preparation of competent escherichia coli cell and conversion, plasmid and digestion with restriction enzyme, DNA
The connection of segmental recovery, linear DNA fragment, the screening of recombinant plasmid and evaluation, pcr amplification reaction, SDS-polyacrylamide gel electrophoresis, protein blot experiment are translated " molecular cloning experiment guide " second edition with reference to Jin Dongyan, Li Mengfeng etc., and Science Press (1992) related Sections carries out.
1.2 the structure of recombinant expression plasmid pPIC9K-M-Np
The structure of middle interstitial granules pMD18-T-M-Np: the pMD18-T-M plasmid is by EcoR I, EcoRV double digestion and recovery; The pMD18-T-Np plasmid is by EcoR I, EcoRV double digestion and recovery.Interstitial granules pMD18-T-M-Np during above recovery product promptly obtained after the T4 ligase enzyme connects.
The structure of purpose plasmid pPIC9K-M-Np: pMD18-T-M-Np is through EcoR I, Not I double digestion and recovery; The pPIC9K plasmid is by EcoR I, Not I double digestion and recovery; Above recovery product after connecting, the T4 ligase enzyme is promptly obtained purpose plasmid pPIC9K-M-Np.
1.3 the preparation of yeast competent cell
The single bacterium colony of picking pichia pastoris phaff bacterium GS115 is to 5ml YPD liquid nutrient medium, and 30 ℃ of joltings are spent the night.Be transferred to next day in the fresh YPD substratum of 500ml, 30 ℃ of joltings are cultured to OD 600=1.3~1.5.In centrifugal 5 minutes of 4 ℃ of 2500rpm, collect thalline.Ice-cold aseptic deionized water suspends, and washs 2 times, and the washing of the sorbyl alcohol of ice-cold aseptic 1M is once got the sorbyl alcohol suspension of precipitation with the aseptic 1M of 1/500 volume ice precooling at last again, is prepared into the yeast competent cell, promptly can be used for transforming.
1.4 the preparation of recombinant bacterial strain
With the recombinant expression plasmid pPIC9K-M-Np Bpu1102I linearizing that makes up, getting linearizing recombinant expression plasmid of 5~20 μ g and freshly prepd GS115 yeast competent cell mixes, with sample injector sample drop is added between 0.2cm electricity revolving cup two electrodes, ice bath 5min, with the ECM830 electroporation in voltage 300V, electric capacity 25 μ F, electricity transforms under the resistance 200 Ω conditions.After the electric shock, add the cold sorbyl alcohol of 1ml 1M ice bath immediately, mixing is got 200~600 μ l bacterium liquid and is coated on the MD selection flat board, hatches 2~3 days for 30 ℃, YPD extracts the yeast genes group with glass bead method after expanding bacterium, with carried genome is the template pcr amplification, selects exogenous origin gene integrator and goes into the interior positive bacteria of yeast genes group, then these bacterium is carried out methanol induction and expresses, select the high expression level bacterial strain, condition such as oxygen saturation is optimized to substratum and when expressing simultaneously.
Upstream primer: 5 '-TACTATTGCCAGCATTGCTGC-3;
Downstream primer: 5 '-GCAAATGGCATTCTGACATCC-3 '.
1.5 the methanol induction secreting, expressing of Yeast engineering bacterium strain
Inoculate single positive strain or glycerol stock (20 ℃ of preservations) in the 100mlYPD substratum, 28~30 ℃, the about 16~18h of 250rpm shaking culture, the centrifugal 10min of 5000rpm receives bacterium, and is resuspended with 100ml BMGY substratum, 28~30 ℃, the 250rpm shake-flask culture makes OD 600Reach 2~6 (about 16~18h), centrifugal collection thalline, precipitate resuspended with the BMMY substratum of 5~10 times of volumes, 28~30 ℃, 250rpm continues shaking culture 2~6d, and after abduction delivering is initial, added methyl alcohol to 0.5~1.0% of cumulative volume every 24 hours, take out the 1ml sample every 24h and be used to test expression amount.
1.6 the SDS-PAGE of exogenous gene expression product analyzes
The engineering yeast cultivated certain hour in the BMMY substratum after, the centrifugal 10min of 5000rpm collects thalline and substratum supernatant, thalline adopts direct boiling lysis cracking tropina in Loadingbuffer, expressing protein in the substratum supernatant is packed in the dialysis tubing, elder generation is 4 ℃ of dialysis 24h in PBS, with PEG20000 carry out 10 times concentrate after, 12h again dialyses in PBS, take out enriched product and 2 times of Loading buffer balanced mix, carry out SDS-PAGE with cracked yeast tropina, the proteic expression of analysis purposes.
1.7 indirect enzyme-linked immunosorbent assay (indirect ELISA)
According to State Standard of the People's Republic of China (GB/T18936-2003) " high pathogenic avian influenza diagnostic techniques " indirect enzyme-linked immunologic adsorption test method, expressed antigen is measured.Process is as follows: remove A1, B1, C1 and D1 hole and do not add sample, stay and do blank zeroing, pPIC9K empty carrier expression product and A type AIV standard antigen are respectively as outside negative control and the positive control, all the other holes get 1: 400 the dilution by Reichl's test, every hole 100 μ l bag is carried out record by plate with the application of sample position.Outwell hole endoperidium liquid, it is inferior to give a baby a bath on the third day after its birth with PBS.Add A type AIV standard serum, Sptting plate is built the rearmounted 37 ℃ of environment of lid effect 30min down.Outwell liquid in the hole, do in that thieving paper is overhead, washing lotion is filled it up with in every hole, outwells after leaving standstill 1~2min, and empty doing repeats to wash 2 times again.Except that A1, B1, C1 and D1 hole, the anti-chicken two anti-100 μ l that other every holes add alkali phosphatase enzyme mark build the rearmounted 37 ℃ of environment of lid effect 30min down.Wash again three times with above-mentioned same method, add substrate and use liquid (adding the BCIP/NBT mixed solution in the alkaline phosphatase damping fluid), every hole 90 μ l, put room temperature lucifuge colour developing 2~3min, add and end liquid (vitriol oil 11.1ml+ distilled water 88.9ml), every hole 90 μ l make its termination reaction.Measuring each hole with microplate reader (is OD in the optical density value of 490nm wavelength 490Value), OD 〉=0.2 are judged to be the positive, and 0.18≤OD<0.2 needs repeated test 1 time, if still then be judged to the positive in this scope, OD<0.18 are judged to be feminine gender.
1.8 the optimization of expression condition
Characteristics during according to the pichia spp abduction delivering are come the optimization expression condition by different dissolved oxygen (95%, 85%, 75%, 65%, 55%), incubation time (2d, 3d, 4d, 5d), methanol concentration (0.5%, 1.0%, 1.5%, 2.0%, 2.5.%), rolling bottle revolution (100,150,200,250) and pH value (3.0,4.0,5.0,6.0,7.0,8.0).
1.9 the yeast transformant genetic stability is analyzed
Respectively positive yeast transformant is carried out the thalline amplification and the abduction delivering in 10 cycles, carry out PCR and identify and detection of expression, analyze foreign gene and whether lose.
2, interpretation of result
2.1 the structure of recombinant expression plasmid pPIC9K-M-Np
Enzyme is cut the evaluation collection of illustrative plates and is seen Figure of description 1, and recombinant plasmid pPIC9K-M-Np size can occur and be the linearizing band of 11300bp behind EcoR I single endonuclease digestion as seen from the figure; Behind the EcoRV single endonuclease digestion, 10100bp and 1200bp two bands can appear; Behind EcoR I, Not I double digestion, 9300bp and 2000bp two bands can appear, prove that this plasmid construction is correct.
2.2 the PCR of yeast recon identifies
Pcr amplification the results are shown in Figure of description 2, as seen from the figure, by universal primer PCR amplification GS115/pPIC9K-M-Np transformant, amplify the band of 2.1kb size, the sizableness that just in time adds secretion signal with goal gene M-Np proves that our goal gene has been integrated in the yeast genes group.
2.3 the SDS-PAGE of expression product
To express supernatant 70% ammonium sulfate precipitation behind the transformant inoculation BMGY and BMMY substratum abduction delivering of screening, and get precipitation and be dissolved among the PBS (PH7.4) of former 1/10 volume, SDS-PAGE is carried out in sampling, and it the results are shown in Figure of description 3.From Figure of description 3 as can be seen, the GS115/pPIC9K-M-Np transformant induced product band that occurs at the 74kDa place conforming to the expectation size.
2.4 expression condition optimum result
Through series optimization, finally determine target protein optimum expression condition be greater than 80% dissolved oxygen, 1% methanol induction, to cultivate 4d, shake bottle rotating speed be 6.0 greater than 200rpm, medium pH value.High expression level amount reaches 18.6% of soluble proteins in the nutrient solution supernatant, is about 52.9mg/L.
2.5 genetic stability analysis
The Yeast engineering bacteria GS115/pPIC9K-M-Np that makes up is seeded in goes down to posterity in YPD liquid nutrient medium and the BMMY substratum after 10 times, carry out the detection of the pcr amplification and the expression product of goal gene.The result shows that Yeast engineering bacteria has good genetic stability, can amplify target gene fragment in the Yeast engineering bacteria karyomit(e) after repeatedly going down to posterity, with the expression that can detect target protein behind the methanol induction in the nutrient solution supernatant.
2.6 indirect ELISA experimental result
Detect GS115/pPIC9K-M-Np expression product measured value OD through ELISA 490〉=0.2, decidable is positive; GS115/pPIC9K expression product measured value OD 490<0.18, decidable is negative.Prove prepared antigen protein tool good biological activity, can be specifically in and M antibody and Np antibody.
3, conclusion
Implement by above method, successfully obtain recombinant plasmid pPIC9K-M-Np, yeast recon GS115/pPIC9K-M-Np, and behind methanol induction, can obtain purpose antigen protein M-Np, the tool biologic activity, can be specifically in and the antibody of M and Np.In the methanol induction process, its expression condition is continued to optimize the output that can increase expression product.Find that simultaneously the yeast transformant genetic stability is stronger.In sum, the present invention successfully obtains the M-Np antigen protein of biologically active, it will all embody important value of exploiting and utilizing in the development of the development of antibody test, AIV recombinant vaccine and AIV Detection of antigen goods, its high efficiency and stability also provide good prospect for the industrialization preparation.
Sequence table
<110〉Jin Ningyi
<120〉expression of avian influenza virus stromatin and nucleoprotein fusion antigen protein preparation
<160>2
<170>PatentIn?version?3.2
<210>1
<211>1974
<212>DNA
<213>Avian
<221>CDS
<222>(1)..(1974)
<400>1
atg?gaa?ttc?gag?ctc?ggt?acc?cgg?gga?tcc?tct?aga?gat?tgc?gga?tcc 48
att?tgg?cgc?caa?gcg?aac?aat?gga?gaa?gat?gca?act?gct?ggt?ctc?act 96
cat?ctg?atg?atc?tgg?cat?tcc?aat?cta?aat?gat?gcc?aca?tac?cag?agg 144
aca?aga?gct?ctc?gtg?cgt?act?ggg?atg?gac?ccc?aga?atg?tgt?tct?cta 192
atg?caa?gga?tca?act?ctc?ccg?agg?aga?tct?gga?gct?gca?ggt?gca?gca 240
gta?aag?gga?gtc?gga?acg?atg?gtg?atg?gag?cta?att?cgg?atg?ata?aag 288
cga?ggg?att?aat?gat?cgg?aat?ttc?tgg?aga?ggt?gaa?aat?ggg?cga?aga 336
acg?agg?att?gca?tat?gag?aga?atg?tgc?aac?atc?ctc?aaa?ggg?aaa?ttc 384
caa?aca?gca?gca?caa?aga?gca?atg?atg?gac?cag?gta?cgg?gaa?agc?agg 432
aat?cct?ggg?aat?gcc?gaa?att?gaa?gat?ctc?atc?ttt?ctg?gca?cgg?tct 480
gca?ctc?atc?ctg?aga?gga?tca?gtg?gct?cac?aag?tcc?tgc?ttg?cct?gct 528
tgt?gtg?tac?ggg?ctt?gct?gta?gcc?agt?gga?tat?gac?ttt?gag?aga?gaa 576
ggg?tat?tct?ctg?gtc?ggg?att?gat?ccc?ttt?cgt?ctg?ctg?caa?aac?agc 624
caa?gtc?ttc?agt?cta?att?aga?cca?aat?gag?aac?cca?gca?cat?aaa?agt 672
caa?ctg?gta?tgg?atg?gca?tgc?cat?tct?gca?gca?ttt?gaa?gat?ctg?agg 720
gtc?tca?agt?ttc?atc?aga?ggg?aca?aga?gta?gtt?cca?agg?gga?caa?cta 768
tct?act?aga?gga?gtt?caa?att?gct?tca?aat?gag?aac?atg?gat?aca?atg 816
gac?tcc?aac?act?cta?gaa?ctg?aga?agc?aga?tat?tgg?gct?ata?aga?acc 864
agg?agt?gga?gga?aac?acc?aat?cag?cag?aga?gca?tct?gca?gga?caa?atc 912
agt?gta?cag?cct?act?ttt?tcg?gta?cag?aga?aat?ctt?ccc?ttc?gag?aga 960
gcg?acc?att?atg?gcg?gca?ttt?aca?ggg?aat?aca?gag?ggc?aga?aca?tct 1008
gac?atg?agg?act?gaa?ata?ata?aga?atg?atg?gaa?agc?gcc?aga?cca?gaa 1056
gat?gtg?tct?ttc?cag?ggg?cgg?gga?gtc?ttc?gag?ctc?tcg?gac?gaa?aag 1104
gca?acg?aac?ccg?atc?ttg?cct?tcc?ttt?gac?atg?agt?aat?gaa?gga?tct 1152
tac?ttc?ttc?gga?gac?aat?gca?gag?gag?tac?gac?aat?ggt?gga?ggc?gga 1200
agc?gga?tat?cga?aag?atg?agt?ctt?cta?acc?gag?gtc?gaa?acg?tac?gtt 1248
ctc?tct?atc?aac?ccg?tca?ggc?ccc?ctc?aaa?gcc?gag?atc?gcg?cag?aga 1296
ctt?gaa?gat?gtc?tct?gca?ggg?aag?aac?aca?gat?cct?gag?gct?ctc?atg 1344
gaa?tgg?cta?aag?aca?aga?cca?atc?ctg?tca?cct?ctg?act?aag?ggg?att 1392
tta?ggg?ttt?gtg?ttt?acg?ctc?acc?gtg?ccc?agt?gag?cga?gga?ctg?cag 1440
cgt?aga?cga?ttt?gtc?caa?aat?gcc?cta?aat?ggg?aat?gga?gac?cca?aac 1488
aac?atg?gac?agg?gca?gtc?aaa?cta?tac?aag?aag?ctt?aag?agg?gaa?atg 1536
acg?ttc?cat?gga?gca?aag?gaa?gtc?gca?ctc?agt?tac?tca?act?ggt?gcg 1584
ctt?gcc?agt?tgc?atg?ggt?ctc?ata?tac?aac?cga?atg?gga?acg?gta?acc 1632
aca?gaa?gtg?gct?ctt?ggc?cta?gta?tgt?gcc?act?tgt?gag?cag?att?gct 1680
gat?tca?cac?cat?agg?tct?cac?aga?cag?atg?gcg?act?acc?acc?aac?cca 1728
cta?atc?agg?cat?gag?aac?aga?atg?gta?cta?gcc?agc?act?aca?gct?aag 1776
gcc?atg?gag?caa?atg?gct?gga?tcg?agt?gag?cag?gca?gcg?gaa?gcc?atg 1824
gag?gtt?gca?agt?cag?gct?agg?cag?atg?gtg?cag?gcg?atg?agg?aca?att 1872
ggg?act?caa?cct?agc?tcc?agt?gca?ggt?ctg?aaa?gat?gat?ctt?att?gaa 1920
aat?ttg?cag?gca?tac?cag?aaa?cgg?atg?ggg?gtg?cag?atg?cag?cga?ttc 1968
aag?tga 1974

Claims (2)

1, the expression preparation method of a kind of avian influenza virus stromatin and nucleoprotein fusion antigen protein is characterized in that:
At first make up plasmid pPIC9K-M-Np: the pMD18-T-M plasmid is also reclaimed by EcoR I, EcoRV double digestion; The pMD18-T-Np plasmid is by EcoR I, EcoRV double digestion and recovery; Interstitial granules pMD18-T-M-Np during above recovery product promptly obtained after the T4 ligase enzyme connects; PMD18-T-M-Np is through EcoR I, Not I double digestion and recovery; The pPIC9K plasmid is by EcoR I, Not I double digestion and recovery; Above recovery product after connecting, the T4 ligase enzyme is promptly obtained purpose plasmid pPIC9K-M-Np;
M-Np albumen pichia spp eukaryotic expression and preparation then: with Bpu1102I linearizing pPIC9K-M-Np recombinant plasmid; After the linearizing its electricity is converted in the GS115 competence, in the MD flat board, cultivate, then the single bacterium colony of picking is recovered in the YPD substratum, put forward the recombinant gene group and carry out the PCR evaluation, the positive strain that filters out shakes bacterium in the BMGY substratum, go in the BMMY substratum after centrifugal to begin methanol induction, gets supernatant after product is centrifugal, add saturated ammonium sulphate albumen, centrifugal collection promptly gets the M-Np antigen protein.
2, the avian influenza virus stromatin and the nucleoprotein fusion antigen protein that are obtained of the described method of claim 1, its gene order is SEQ ID NO:1.
CN 200510017148 2005-09-21 2005-09-21 Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation Pending CN1936009A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510017148 CN1936009A (en) 2005-09-21 2005-09-21 Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510017148 CN1936009A (en) 2005-09-21 2005-09-21 Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation

Publications (1)

Publication Number Publication Date
CN1936009A true CN1936009A (en) 2007-03-28

Family

ID=37953752

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510017148 Pending CN1936009A (en) 2005-09-21 2005-09-21 Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation

Country Status (1)

Country Link
CN (1) CN1936009A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103901202A (en) * 2014-04-04 2014-07-02 中国人民解放军成都军区疾病预防控制中心 Universal competitive ELISA detection method based on common epitope influenza A virus antibody
CN108409842A (en) * 2018-03-15 2018-08-17 山东省农业科学院畜牧兽医研究所 A kind of monoclonal antibody and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103901202A (en) * 2014-04-04 2014-07-02 中国人民解放军成都军区疾病预防控制中心 Universal competitive ELISA detection method based on common epitope influenza A virus antibody
CN103901202B (en) * 2014-04-04 2015-08-12 中国人民解放军成都军区疾病预防控制中心 Based on the universal competitive ELISA detection method of total epi-position influenza A virus antibody
CN108409842A (en) * 2018-03-15 2018-08-17 山东省农业科学院畜牧兽医研究所 A kind of monoclonal antibody and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103585625B (en) A kind of porcine epizootic diarrhea recombinant baculovirus genetic engineering subunit vaccine and preparation method thereof and application
CN107238702A (en) Detect the enzyme linked immunological kit of PPR virus antibody
CN101736062B (en) Method for preparing recombinant porcine alpha interferon standard substance
CN101508978B (en) Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof
CN107098979A (en) PPR virus H F fusion proteins and its relevant biological material and application
CN1936014B (en) H5 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein and preparing method
CN102212134A (en) Polyclonal antibody against outer membrane protein of Candidatus liberobacter asiaticum, and preparation method and application thereof
CN107435041A (en) Chimeric the newcastle Disease poisonous carrier H9 live vaccines Candidate Strain and its construction method for overcoming chicken Newcastle disease maternal antibody to influence
CN102680699B (en) ELISA (enzyme-linked immunosorbent assay) detection method for identifying fowl adenovirus group I (FAVI) infection
CN104548088A (en) Method for preparing bivalent vaccine of newcastle disease virus La Sota strain and infectious bronchitis virus N-S multi-epitope protein
CN107759674A (en) A kind of Mycoplasma bovis immune-related albumen, the detection kit containing the albumen and its purposes in Mycoplasma bovis antibody test
CN110272910A (en) A kind of outer membrane vesicles and its application of the recombinant vector including JEV antigen gene, recombinant bacterial strain and submission JEV antigen
CN102618557B (en) Recombinant avian flavivirus E protein and application thereof
CN1936009A (en) Avian influenza virus matrix protein and nucleoprotein fusion antigen protein expression preparation
CN107860921A (en) Pseudorabies virus antibody Quantitative detection card and application method
CN1935995A (en) H7 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein
CN107287268A (en) A kind of adjuvant of the nucleic acid vaccine immunity originality of enhancing HIV 1
CN107254450A (en) The chimeric Newcastle Disease Virus Vaccine carrier Candidate Strain and construction method for overcoming newcastle disease maternal antibody to influence
CN107167609A (en) Distinguish the antibody indirect ELISA detection method of pig blue-ear disease street strain and the strain of vaccine strain Tianjin
CN101724692A (en) Primer and diagnosis method used for diagnosing mulberry bacterial wilt disease
CN103387604B (en) CD8+T cell epitope polypeptide of S1 protein of chicken IBV (Infectious Bronchitis Virus) S1 protein
CN103570832B (en) A kind of pig source chimeric antibody of anti-haemophilus parasuis and construction process thereof and application
CN102012432B (en) Colloidal gold immunochromatographic test paper based on recombinant UL51 protein as well as preparation method and application thereof
CN107236047A (en) Recombinate the solubility expression method of PPR virus H F fusion proteins
CN1935996A (en) H9 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070328